Cornea

Okyo Pharma has announced that screening and recruitment has been initiated for a phase 2 trial of OK-101 to treat neuropathic corneal pain, with plans to enroll 48 patients, according to a company press release.

BARCELONA, Spain — One-year results with the second-generation ELZA-sub400 protocol for corneal cross-linking showed efficacy in halting keratoconus progression in ultrathin corneas, according to a study presented here.

Screening for keratoconus should be part of all pediatric eye exams. While this disease typically manifests around puberty, there can be signs of progressive keratoconus much earlier in some cases.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Penny A. Asbell, MD, FACS, MBA, of the University of Memphis, discusses results from the ARMOR surveillance study.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Analisa Arosemena, MD, of CorrectVision Laser Institute discusses Vevye for the treatment of dry eye disease.

In this Healio Video Perspective from the World Ophthalmology Congress, John D. Sheppard, MD, MMSc, FACS, of Virginia Eye Consultants discusses Miebo’s efficacy for dry eye disease in various patient subgroups.

Spencer Trask & Co. announced the launch of Signal12, a clinical-stage dry eye company that plans to advance Pro-ocular for the treatment of dry eye disease, according to a press release.

Patients with dry eye disease experienced improvements in ocular discomfort after treatment with reproxalap, according to a press release from Aldeyra Therapeutics.

Bausch + Lomb has acquired Trukera Medical in an effort to expand its position in dry eye care, according to a press release.

KIAWAH ISLAND, S.C. — A study suggested that electrocardiogram screening should be performed in patients with sarcoidosis-associated uveitis because life-threatening cardiac involvement may be present even without symptoms.